Skip to content
CompanySight
Company No. 14212968 · Incorporated 4 Jul 2022

Orfonyx Bio Ltd

Registered name: ORFONYX BIO LTD

Part of Oxford Science Enterprises PLC group

Orfonyx Bio Ltd does not publish its revenue or profit. Its accounts to 31 Dec 2025 show net assets of £486k and 6 employees.

Orfonyx Bio Ltd did not publish its revenue or profit — small companies aren’t required to file a profit & loss account. Its accounts for the year to 31 Dec 2025 showed net assets of £486k and 6 employees. The company is classified under “research and experimental development on biotechnology” and is based in Oxford; we hold 5 years of its filed accounts.

Balance sheet onlySection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology
Status
Active
Location
Oxford, South East
Age
4 yrs · since 2022
Type
Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Small team

Revenue not disclosed

Orfonyx Bio Ltd’s accounts for the year to 31 Dec 2025 contain a balance sheet but no profit & loss account, so its revenue and profit are not public. UK small and micro-entity companies are not required to publish a P&L — this is normal and says nothing about how the business is performing.

We never estimate revenue. Below you’ll find the balance-sheet figures that were filed — useful as indirect signals of momentum, but they are not revenue or profit.

Employees
6
Net assets
£486k

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

5 filed years

Financial history

Multi-year financials, oldest to newest
Year to3 Jul 202231 Jul 202331 Jul 202431 Dec 202431 Dec 2025
DisclosureNo P&LNo P&LNo P&LNo P&LNo P&L
Profit & loss
Revenue (turnover)—————
Profit (best available)—————
Employees (average)—2466
Ratios
Profit margin—————
Growth (year on year)
Headcount growth——▲100%——
Balance sheet — indirect signals, not revenue
Cash at bank—£352k£1.2m£494k£238k
Net assets—£403k£1.5m£847k£486k
Fixed assets£0£31.8k£221k£207k£173k
Current assets—£479k£1.5m£770k£284k
Debtors—£128k£269k£276k£45.1k
Deferred income—£13.4k£33k£33.3k£29.2k
SourceFullAccounts · bulk data Apr 2024FullAccounts · bulk data Apr 2024FullAccounts · bulk data Apr 2025FullAccounts · bulk data Aug 2025FullAccounts · bulk data Aug 2026
Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets
—
Now £486k
Cash at bank
—
Now £238k
Headcount
—
Now 6
Deferred income
—
Now £29.2k
Fixed assets
—
Now £173k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

  1. Oxford Science Enterprises PLCultimate parent75–100%
  2. Orfonyx Bio Ltdthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (17)

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025, from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.